Content about rivastigmine

March 12, 2013
Actavis seeks approval for Alzheimer's patch

Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

PARSIPPANY, N.J. — Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

The generic drug maker said it had filed with the Food and Drug Administration an amendment to its regulatory application for rivastigmine transdermal system to include the 13.3 mg-per-24-hours dosage strength, a generic version of Novartis' Exelon. Novartis filed suit against Actavis on Thursday in the U.S. District Court for the District of Delaware seeking to prevent commercialization of the generic version.

November 11, 2011
Watson files for approval of generic dementia treatment

Watson Pharmaceuticals is challenging Swiss drug maker Novartis' patent on a drug used to treat dementia, Watson said.

PARSIPPANY, N.J. — Watson Pharmaceuticals is challenging three of Swiss drug maker Novartis' patents on a drug used to treat dementia, Watson said.

The company said subsidiary Watson Labs had filed for approval generic rivastigmine transdermal system patches in the 4.6-mg and 9.5-mg strengths, both designed to last for 24 hours, with the Food and Drug Administration. The patches are used to treat mild to moderate dementia associated with Alzheimer's or Parkinson's disease.

September 22, 2011
Dr. Reddy's launches generic Alzheimer's drug

Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.

NEW YORK — Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.

Dr. Reddy's announced the launch of rivastigmine tartrate capsules in the 1.5-mg, 3-mg, 4.5-mg and 6-mg strengths.

The drug is a generic version of Novartis' Exelon. Exelon and other generic versions of the drug had sales of about $92.6 million during the 12-month period ended in June, according to IMS Health.

July 6, 2010
Sandoz launches generic Exelon

Sandoz has launched a version of a drug for treating dementia, the generics arm of...

July 5, 2010
Caraco launches generic dementia treatment

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 30, 2010
Watson's generic Exelon makes market debut

Watson Pharmaceuticals has launched a generic version of a drug used to treat dementia under...